Skip to content

Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the Microbile Registry

Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the Microbile Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06115564
Acronym
Microbile
Enrollment
200
Registered
2023-11-03
Start date
2022-07-01
Completion date
2023-12-31
Last updated
2023-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Disease, Biliary Stricture, Choledocholithiasis, Jaundice; Malignant, Jaundice, Obstructive

Brief summary

The study is a prospective evaluation of the microbial assessment in patients undergoing to ERC with naive papilla; the population includes all the indication to biliary drainage.

Interventions

None listed

Sponsors

Azienda Unità Sanitaria Locale della Romagna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Main inclusion criteria for patient enrollment were: ability to provide an informed consent; age \>/=18 years; any benignant or malignant ERCP indication. All subjects were excluded from the study: * Patients who have already undergone endoscopic sphincterotomy * Patients unable to express informed consent * Pregnant or breastfeeding women * Patients with anatomical post-surgical alterations of the upper gastrointestinal (GI) tract

Design outcomes

Primary

MeasureTime frameDescription
Microbial assessment in patients undergoing to ERC with naive papillaJuly 2022 to 2023Coltural assessment of the bile samples obtained pre- and post-sphincterotomy during ERC in naive papilla.

Secondary

MeasureTime frameDescription
Check the presence of a possible association between specific biliary bacterial strains and definite pancreaticobiliary disorders.July 2022 to 2023Check the presence of a possible association between specific biliary bacterial strains and definite pancreaticobiliary disorders.
MDR and sentinel germs detectionJuly 2022 to 2023Determine the presence and the prevalence of MDR organisms and sentinel germs in bile.
differences in the microbial community before and after sphincterotomy.July 2022 to 2023Evaluation of differences in the microbial community before and after sphincterotomy.
Identify possible correlations between pre sphincterotomy positive biliary cultures, polymicrobial population and MDR organisms with several clinical features and with laboratory signs of acute cholangitis.July 2022 to 2023Identify possible correlations between pre sphincterotomy positive biliary cultures, polymicrobial population and MDR organisms with several clinical features and with laboratory signs of acute cholangitis.
Identify potential differences in the pre sphincterotomy biliary microbial community depending on type of jaundice (benign or malignant).July 2022 to 2023Identify potential differences in the pre sphincterotomy biliary microbial community depending on type of jaundice (benign or malignant).

Countries

Italy

Contacts

Primary ContactCarlo Fabbri, MD
carlo.fabbri@auslromagna.it+39 3389353104

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026